After Eric Tennant’s Death, West Virginia Takes Aim at Prior Authorization

Key Takeaways

• WV law lets workers change treatments without new prior auth
• Switch must be medically appropriate and cost equal or lower
• Prior‑auth rules vary widely across Aetna, Humana, UnitedHealthcare
• Only 14% of prior‑auth requirements overlap among the three insurers
• Law signals growing political pressure to curb insurer authorization delays

Pulse Analysis

The prior‑authorization process, originally a back‑office tool for insurers to verify medical necessity, has evolved into a major barrier to timely care. High‑profile cases such as Nataline Sarkisyan in 2007 and, more recently, West Virginia coal‑mining safety instructor Eric Tennant illustrate how delays can turn treatable conditions into fatal outcomes. Tennant’s insurer classified his cancer regimen as “experimental,” forcing a months‑long appeal that left him ineligible for the intended procedure. These stories have amplified criticism of a system that often prioritizes cost containment over patient outcomes, prompting legislators to seek concrete safeguards.

West Virginia’s new statute directly addresses that criticism by permitting beneficiaries of the state employee health plan to switch to an alternative, medically appropriate therapy of equal or lower cost without restarting the prior‑authorization workflow. The law does not eliminate prior authorization altogether; instead, it creates a streamlined pathway for treatment changes, reducing administrative friction and preserving continuity of care. By tying the switch to cost parity, the legislation balances payer concerns with patient needs. Early observers expect faster access to approved therapies, fewer appeals, and a measurable drop in treatment‑delay incidents within the state’s public‑sector workforce.

The West Virginia measure arrives amid mounting evidence that prior‑authorization criteria are fragmented across the nation’s largest insurers. A recent Annals of Internal Medicine analysis identified 4,645 services requiring authorization, yet only 14% of those requirements overlapped among Aetna, Humana and UnitedHealthcare. Such inconsistency fuels inefficiency and hampers clinicians who must navigate divergent rules for the same procedure. While the state law is limited to a specific employee plan, it signals growing political willingness to curb insurer dominance—a trend echoed in bipartisan congressional proposals and CMS’s experimental WISeR program that explores AI‑driven authorizations. If replicated, these reforms could reshape utilization management on a national scale.